Hims & Hers Health shares jumped 7% after announcing expanded partnership with Eli Lilly to prescribe GLP‑1 weight‑loss drugs.
The new platform lets providers send prescriptions for Zepbound vials, KwikPen and Foundayo to LillyDirect pharmacy with self‑pay pricing.
Hims & Hers also recently partnered with Novo Nordisk for Wegovy access, expanding its US weight‑loss membership offering comprehensive support services.